Top three insurers reaped $7.3 billion through their drug middlemen's markups, FTC says
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" prescription price hikes of 1,000% or more.
PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate billions in revenue through
FTC finds middlemen inflate specialty generic drug prices by billions of dollars
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs between 2017 and 2022,
US FTC Finds Major Pharmacy Benefit Managers Inflated Drug Prices for $7.3 Billion Gain
UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts -- marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue in excess of the acquisition costs of the drugs,
FTC takes fresh swipe at drug middlemen, says some prices marked up over 1,000%
The drug middlemen known as pharmacy-benefit managers took another body blow from regulators on Tuesday, as they were criticized for charging way more for some “critical” prescription drugs than it cost them.
FTC says pharmacy benefits managers marked-up generic drug prices for $7.3bn gain
Regulator’s report finds companies ‘hiked costs’ for a range of medicines, including cancer and HIV treatments
FTC says ‘Big 3 PBMs’ marked up generic drugs by thousands of percent
The Federal Trade Commission published a second interim staff report on the prescription drug middleman industry, which it says focuses on
FTC Release: FTC Releases Second Interim Staff Report on Prescription Drug Middlemen
Report finds PBMs charge significant markups for cancer, HIV, and other critical specialty generic drugs The Federal Trade Commission today published a second interim staff report on the prescription drug middleman industry,
FTC releases new findings in drug price inflation investigation
The report found top pharmacy benefit managers made more than $7.3 billion by marking up the prices of dozens of generic ...
Republican bill seeks to curtail US FTC's merger-busting powers
The U.S. Federal Trade Commission's merger-busting, antitrust enforcement powers are coming under threat as conservatives ...
ConsumerAffairs1h
Another FTC report is highly critical of pharmacy benefit managers
In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...
Apartment giant Greystar facing FTC lawsuit over misleading rental fees
The suit accuses the company of falsely advertising rental prices by failing to inform renters of numerous mandatory fees.
FTC set to sue Deere over equipment repair practices, Bloomberg News says
The U.S. Federal Trade Commission has prepared a lawsuit against Deere & Co alleging the company's agricultural equipment ...
Federal Trade Commission accuses Greystar of deceptive practices, hidden fees
The antitrust agency recently created a rule regarding junk fees, but its application to the multifamily sector is unclear.
Federal trade commission
The IFA has formally called on the Federal Trade Commission to shift its focus away from increased regulation of the franchise business model, arguing that the commission's recent actions exceed its ...
Will ‘click to cancel’ get canceled? New FTC rule faces legal, political challenges
It takes effect Tuesday but its fate is already in doubt. The new FTC rule faces legal challenges and possible opposition ...